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OBJECTIVES: The enhanced recovery after surgery (ERAS) protocol recommends prevention of intraoperative
hypothermia. However, the beneficial effect of maintaining normothermia after radical cystectomy has not
been evaluated. This study aimed to investigate the efficacy of fluid warming nursing in elderly patients
undergoing Da Vinci robotic-assisted laparoscopic radical cystectomy.
METHODS: A total of 108 patients with bladder cancer scheduled to undergo DaVinci robotic-assisted
laparoscopic radical cystectomy were recruited and randomly divided into the control group (n=55), which
received a warming blanket (43oC) during the intraoperative period and the warming group (n=53), in which all
intraoperative fluids were administered via a fluid warmer (41oC). The surgical data, body temperature,
coagulation function indexes, and postoperative complications were compared between the two groups.
RESULTS: Compared to the control group, the warming group had significantly less intraoperative transfusion
(p=0.028) and shorter hospitalization days (po0.05). During the entire intraoperative period (from 1 to 6h),
body temperature was significantly higher in the warming group than in the control group. There were
significant differences in preoperative fibrinogen level, white blood cell count, total bilirubin level,
intraoperative lactose level, postoperative thrombin time (TT), and platelet count between the control and
warming groups. Multivariate linear regression analysis demonstrated that TT was the only significant factor,
suggesting that the warming group had a lower TT than the control group.
CONCLUSION: Fluid warming nursing can effectively reduce transfusion requirement and hospitalization days,
maintain intraoperative normothermia, and promote postoperative coagulation function in elderly patients
undergoing Da Vinci robotic-assisted laparoscopic radical cystectomy.
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’ INTRODUCTION
Bladder cancer is the 9th most common malignancy and
the 13th leading cause of death worldwide (1). It is primarily
a disease of the elderly, with a median age of 72 years at
diagnosis (2). Radical cystectomy is the gold standard
treatment for muscle-invasive or high-grade non-muscle-
invasive bladder cancer (3). With the development of the
technique of minimally invasive surgery, Da Vinci robot-
assisted radical cystectomy has become the primary and gold
standard treatment for bladder cancer as it can better
preserve nerve and vessels, which has been shown to reduce
blood loss and transfusion, narcotic requirement, time to
regular diet, and hospitalization days (3–5). However, the
use of robotic-assisted surgery usually increases the overall
operating time and requires prolonged artificial pneumo-
peritoneum and some special patient positioning, which
could affect the patient’s pathophysiological conditions and
easily induce perioperative hypothermia, especially in the
elderly (6). Intraoperative hypothermia can induce a series of
perioperative complications, such as postoperative delayed
wakefulness, shivering, coagulopathy, agitation, hypoxe-
mia, poor wound healing, and headache (7). It has been
shown that intraoperative hypothermia is significantly asso-
ciated with a higher short-term readmission rate and mor-
tality in elderly patients (8). Despite this, few studies exist
on temperature management in Da Vinci robotic-assisted
surgery.
Since infusing cold saline or packed red blood cells cau-
ses a marked decrease in patient’s body temperature (9),DOI: 10.6061/clinics/2020/e1639
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pre-warmed infusions (to 38–42oC) is an important stra-
tegy to maintain intraoperative normothermia (10,11). The
common methods of pre-warmed infusions include a
double-wall infusion line and a fluid warming device (12,13).
Intravenous fluids warming is one of the most effective
strategies for intraoperatively maintaining normothermia
(14,15). Intravenous fluid warming has been shown to
effectively maintain the core temperature in laparoscopic
colorectal surgery (16). The Enhanced Recovery After Surgery
(ERAS) Society guidelines for perioperative care after radical
cystectomy for bladder cancer strongly recommend preven-
tion of intraoperative hypothermia (17). However, the bene-
ficial effect of maintaining normothermia during radical
cystectomy has not been evaluated(18). Therefore, this study
aimed to investigate the efficacy of fluid warming in elderly
patients with bladder cancer undergoing Da Vinci robotic-
assisted laparoscopic radical cystectomy.
’ METHODS
Participants and study design
A total of 108 patients with bladder cancer scheduled
to undergo DaVinci robotic-assisted laparoscopic radical
cystectomy were recruited into this trial. Other inclusion
criteria were American Society of Anesthesiologists (ASA)
Score I-III and age 50-79 years. Patients with a history of
cerebral infarction, mental abnormalities, preoperative urin-
ary tract infection, or severe lung infection or disease were
excluded. This study was approved by the institutional
review board of our hospital and written informed consent
was waived by the Institutional Review Board due to the
retrospective nature of this study.
Fluid warming protocol
Prior to the study, all nursing staff received training for
the procedure of fluid warming and the data collection. The
108 enrolled patients were randomly divided into the control
group (n=55) and the warming group (n=53). All patients
underwent Da Vinci robot-assisted laparoscopic radical
cystectomy at room temperature under the same anesthesia
treatment.
In the warmed fluid group, all intraoperative fluids were
administered via the Rangert Blood/Fluid Warming Unit
(3M, St. Paul, MN, USA) using a setpoint of 41oC. The
patients in the control group used a warming blanket
(setpoint=43oC) during the intraoperative period.
Data collection
Demographic (sex, age) and baseline clinical characteristics
(ASA score, Cardiac function (assessed by determining the
ejection fraction), and body mass index [BMI]) were collected.
Surgical information included intraoperative transfusion,
intraoperative blood loss, intraoperative warming time of
transfusion, operative time, anesthesia time, recovery room
to extubation time, post-anesthesia care unit (PACU) stay
time, postoperative flatulence, loss of blood, reoperation
due to bleeding, hospitalization days, and medical expenses.
Patient’s nasopharyngeal temperature was measured using
the Carefusion Temperature Probe (400 Series, GE Healthcare,
USA) with the Carescape Monitor B650, GE Healthcare)
during the whole perioperative period. Biochemical examina-
tion results including coagulation function indexes (prothrom-
bin time activated partial thromboplastin time, thrombin
time), fibrinogen; white blood cell, platelet, total bilirubin,
pH, glucose, lactose were collected during the perioperative
period.
Postoperative complications including cold shivering, pneu-
monia, pulmonary embolism, urinary fistula, and intestinal
obstruction were recorded. All data was compared between
the two groups.
Statistical analysis
Continuous variables were presented as mean±SD (stan-
dard deviation) while categorical data were indicated by
number and percentage (%). Student’s independent t-test was
used to compare the differences between groups. If normality
of continuous variables was not assumed, median (range) and
non-parametric analysis Mann-Whitney U test would be used
instead. Chi-square test and Fisher’s exact test (if any expected
value lower than 5 was observed) were used for categorical
data. Two-way mixed design ANOVA was used to test the
significance of main effect (time, group) and interaction effect
(time*group). Univariate and multivariate linear regression
models were used to investigate the significance of group
factor to the differences between pre/peri-operative and
postoperative index. A p-value lower than 0.05 would be
recognized as reaching significance of each test. All analyses
were performed using IBM SPSS Version 20 (SPSS Statistics
V20, IBM Corporation, Somers, New York).
’ RESULTS
Demographic and clinical characteristics
A total of 108 patients (mean age= 62.20±11.05 years,
range: 26-87, 82.41% male) undergoing DaVinci assisted
laparoscopic radical cystectomy were enrolled, and ran-
domly divided into the warming group (n=53) and control
group (n=55). There was no significant difference in demo-
graphic and clinical characteristics between the warming and
control groups (all p40.05, Table 1).
Perioperative information
The perioperative information was compared between
the two groups. As shown in Table 2, the warming group
had significantly less intraoperative transfusion (p=0.028)
and shorter hospitalization days (both postoperative and
total hospitalization, po0.05) than the control group. How-
ever, there was no significant difference in perioperative
blood loss, operative time, anesthesia time, time from enter-
ing recovery room to extubation, PACU stay time, time to
postoperative flatulence, blood loss, reoperation due to
bleeding, and medical expenses (all p40.05).
Change of body temperature during the
perioperative period
Patient’s body temperature was recorded at preoperative,
intraoperative and postoperative periods. As shown in
Table 3, during the entire intraoperative period (from 1 to
6h), the warming group had significantly higher body
temperature than the control group (all po0.05). No
significance was found in preoperative and recovery room
periods (p40.05). At day 3 after the operation, the body
temperature was slightly but significantly higher in control
group than in the warming group (po0.05).
Perioperative laboratory results
Laboratory results were compared between groups. There
were significant differences in preoperative FIB, white blood
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cell, total bilirubin; intraoperative lactose; and postopera-
tive thrombin time (TT) between the control and warming
groups (all po0.05, Table 4). The difference between pre- and
postoperative TTwas also different between groups (p=0.004,
Table 4).
Linear regression was used to investigate the effect of
group factor on the differences between preoperative/intra-
operative and postoperative results. The multivariate model
was controlled with patient’s age, gender, and ASA classi-
fication. The result showed that TT was the only significant
Table 1 - Demographic and clinical characteristics.
Parameters Control (n=55) Warming (n=53) Total (n=108) p
Sex 0.240
Male 43 (78.18) 46 (86.79) 89 (82.41)
Female 12 (21.82) 7 (13.21) 19 (17.59)
Age, years 63.55±10.38 60.81±11.65 62.20±11.05 0.155
ASA classification 0.124
II 23 (41.82) 30 (56.60) 53 (49.07)
III 32 (58.18) 23 (43.40) 55 (50.93)
Cardiac functiona 0.66±0.06 0.66±0.05 0.66±0.06 0.850
BMI 23.04±3.20 23.44±2.83 23.24±3.02 0.545
ASA, American Society of Anesthesiologists; BMI, Body Mass Index.
a Cardiac function was assessed by determining the ejection fraction (EF).
Table 2 - Patient’s operative information.
Parameters Control (n=55) Warming (n=53) Total (n=108) p
Intraoperative transfusion, ml 2153.64±671.91 1903.30±491.32 2030.79±600.80 0.028
Intraoperative blood loss, ml 212.73±525.31 141.13±108.82 177.59±382.50 0.193
Intraoperative warming time of transfusion,
min
- 336.43±88.91 336.43±88.91 -
Operative time, min 346.51±94.85 322.57±81.29 334.76±88.86 0.190
Anesthesia time, min 507.38±104.83 476.68±93.28 492.31±100.06 0.132
Recovery room to extubation time, min 26.39±12.70 26.62±14.31 26.50±13.44 0.909
PACU stay time, min 70.17±19.55 75.91±27.84 72.90±23.90 0.410
Postoperative flatulence, day 3.71±1.71 3.70±1.39 3.70±1.55 0.768
Loss of blood, ml
Operative day 429.42±214.71 431.32±164.92 430.35±191.01 0.268
Day 1 after surgery 434.04±274.84 421.36±181.62 427.81±232.79 0.683
Day 2 after surgery 326.73±203.61 313.72±180.74 320.34±191.94 0.822
Day 3 after surgery 300.27±269.22 312.06±271.74 305.83±269.16 0.718
Reoperation due to bleeding 0.580
No 53 (96.36) 52 (98.11) 105 (97.22)
Yes 2 (3.64) 1 (1.89) 3 (2.78)
Hospitalization, days
Postoperative 20 (5-75) 16 (5-48) 18 (5-75) o0.001
Total 34.07±10.87 23.62±6.82 28.94±10.48 o0.001
Medical expenses
Anesthesia 12056.21 (9285.64-23325.39) 12861.46 (7923.50-19068.38) 12478.44 (7923.50-23325.39) 0.557
Total 107026.61 (79421.88-
359872.75)
103629.18 (82531.73-
183466.73)
105198.58 (79421.88-
359872.75)
0.823
PACU; post-anesthesia care unit.
Table 3 - Change in the patient’s body temperature during the perioperative period.
Parameters Control (n=55) Warming (n=53) Total (n=108) p
Preoperative 36.45±0.36 36.48±0.35 36.47±0.35 0.641
Intraoperative
1 hour 36.05±0.42 36.22±0.47 36.13±0.45 0.036
2 hours 35.80±0.39 36.14±0.45 35.97±0.45 o0.001
3 hours 35.54±0.44 36.10±0.40 35.81±0.50 o0.001
4 hours 35.27±0.39 36.09±0.39 35.67±0.56 o0.001
5 hours 35.06±0.34 36.12±0.30 35.55±0.62 o0.001
6 hours 34.90±0.30 36.01±0.33 35.29±0.62 o0.001
Postoperative
In recovery room 36.25±0.38 36.12±0.38 36.19±0.38 0.103
Back to the ward 36.42±0.37 36.47±0.39 36.44±0.38 0.564
Day 1 37.07±0.44 36.95±0.43 37.01±0.44 0.160
Day 2 36.92±0.42 36.87±0.32 36.89±0.37 0.310
Day 3 36.93±0.54 36.74±0.30 36.84±0.45 0.024
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factor (Table 5), suggesting that the warming group had
lower TT level than the control group.
Postoperative complications
There was no significant difference in postoperative
complications between the two groups, including cold
shivering in the recovery room, pneumonia, pulmonary
embolism, urinary fistula, and intestinal obstruction (Table 6,
all p40.05).
’ DISCUSSION
Under normal physiological conditions, the body core
temperature fluctuates only within a narrow range (about
±0.2oC), while under anesthesia, the range is significantly
increased to±4oC (19). In addition, body temperature under
anesthesia is more easily affected by external factors. Robot-
assisted laparoscopic radical cystectomy increases the overall
operating time and requires prolonged anesthesia (6). Most
of the patients receiving radical cystectomy are elderly and
Table 4 - Laboratory results during perioperative period.
Parameters Control (n=55) Warming (n=53) Total (n=108) p
Preoperative
PT 11.83±0.82 11.61±0.92 11.72±0.87 0.121
APTT 25.59±4.33 25.34±4.00 25.46±4.15 0.907
TT 18.23±2.82 17.32±1.86 17.78±2.43 0.080
FIB 3.78±2.92 3.07±1.17 3.43±2.25 0.034
WBC 6.51±2.06 7.78±2.90 7.14±2.58 0.023
Platelet 229.96±59.78 259.09±71.17 244.26±66.92 0.056
Total bilirubin 13.36±4.91 11.13±3.93 12.27±4.58 0.012
Intraoperative (average)
PH 7.31±0.06 7.33±0.05 7.32±0.06 0.210
GUL 6.27±1.12 6.26±1.13 6.27±1.12 0.875
LAC 0.69±0.20 0.85±0.39 0.77±0.31 0.016
Postoperative
PT 15.44±13.46 12.33±0.89 13.99±9.91 0.069
APTT 30.41±9.21 27.14±4.84 28.89±7.62 0.245
TT 17.84±5.19 15.72±1.48 16.85±4.04 0.010
FIB 3.67±1.40 3.32±0.99 3.50±1.23 0.450
WBC 11.05±4.30 12.22±4.12 11.62±4.24 0.219
Platelet 187.91±53.33 229.83±67.46 208.48±63.95 0.002
Total bilirubin 14.26±5.90 13.59±6.81 13.93±6.34 0.378
pH 7.34±0.04 7.35±0.04 7.35±0.04 0.084
GUL 7.18±1.75 7.10±1.98 7.14±1.85 0.453
LAC 1.18±0.68 1.25±0.69 1.21±0.68 0.414
Difference between preoperative and postoperative period
PT 3.50±13.40 0.66±1.13 2.18±9.86 0.156
APTT 4.14±6.30 1.53±3.89 2.93±5.43 0.127
TT 0.26±4.44 -2.14±2.42 -0.86±3.81 0.004
Fibrinogen 0.24±1.23 0.46±1.39 0.35±1.30 0.457
WBC 4.53±4.33 4.43±3.67 4.48±4.01 0.939
Platelet ++ -29.26±36.51 -35.78±36.56 0.161
Total bilirubin 0.89±5.58 2.46±5.83 1.66±5.73 0.265
pH 0.03±0.06 0.02±0.05 0.03±0.05 0.887
Glucose 0.87±1.48 0.85±1.54 0.86±1.50 0.430
Lactose 0.48±0.69 0.42±0.65 0.46±0.67 0.958
PT, prothrombin time; APTT, activated partial thromboplastin time; TT, thrombin time; WBC, white blood cell; Platelet; pH.
Table 5 - Univariate and multivariate linear regression results.
Linear regression
Univariate Multivariate
B (95% CI) p B (95% CI) p
PT -2.84 (-8.03-2.34) 0.277 -3.11 (-8.72-2.51) 0.272
APTT -2.61 (-5.42-0.19) 0.067 -1.59 (-4.37-1.20) 0.259
TT -2.40 (-4.32--0.48) 0.015 -2.46 (-4.47--0.44) 0.018
Fibrinogen 0.22 (-0.47-0.92) 0.522 0.30 (-0.45-1.05) 0.426
WBC -0.10 (-1.63-1.44) 0.900 -0.08 (-1.64-1.48) 0.920
Platelet 12.79 (-1.01-26.59) 0.069 11.17 (-2.83-25.17) 0.117
Total bilirubin 1.57 (-0.61-3.74) 0.156 1.53 (-0.71-3.77) 0.178
pH 0.00 (-0.03-0.02) 0.743 0.00 (-0.03-0.02) 0.871
Glucose -0.02 (-0.65-0.61) 0.952 0.03 (-0.63-0.68) 0.935
Lactose -0.06 (-0.34-0.22) 0.677 0.00 (-0.29-0.28) 0.975
PT, prothrombin time; APTT, activated partial thromboplastin time; TT, thrombin time; WBC, white blood cell; Platelet; pH.
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are therefore more likely to develop perioperative hypother-
mia than young patients due to the degeneration of their body
homeostasis ability. Therefore, maintaining normothermia is
an important measure to reduce perioperative complications.
At present, intraoperative temperature maintaining devi-
ces include forced-air warming blankets, heating mattresses,
circulating-water garment systems (20), and fluid warming
system (16). The disadvantage of warming blankets and
heating mattresses is that the temperature sensor of elderly
patients may degenerate, which may cause burns or thermal
hypersensitivity. Water in circulating-water garment systems
is considered as a potential source of pathogen contamina-
tion in hospitals and can be a source of infection if not
properly maintained. The fluid warming system supplies
heat by inserting the infusion catheter into the metal heating
plate without circulating water. Constant-temperature fluids
or blood can be delivered into every part of the body. Choi
et al. have demonstrated that intravenous fluid warming can
effectively maintain intraoperative normothermia in patients
undergoing laparoscopic colorectal surgery (16). However,
the effectiveness of warming intravenous fluid has not been
evaluated in robotic-assisted laparoscopic surgery.
In this study, we investigated the efficacy of fluid warming
in elderly patients undergoing Da Vinci robotic-assisted
laparoscopic radical cystectomy. The results showed that
during the entire intraoperative period, body temperature
was significantly higher in the warming group than in the
control group. Especially at 6h after surgery start, the core
temperature dropped to 34.9oC in the control group but still
maintained at 36.01oC in the warming group. This data
suggested that our fluid warming protocol can effectively
maintain normothermia during operation, which is consis-
tent with the results of the studies conducted in laparoscopic
colorectal surgery (16).
In the current study, the warming group had significantly
less intraoperative transfusion than the control group, sug-
gesting that fluid warming can significantly reduce intra-
operative transfusion requirement. This finding is in line
with the results of a meta-analysis, including 10 studies by
Rajagopalan et al., which shows that mild hypothermia
(decrease by o1oC) significantly increases blood loss by
approximately 16% and increases transfusion risk by 22%
(21). By contrast, maintaining intraoperative normothermia
can effectively reduce blood loss and transfusion require-
ment (21). However, although the intraoperative blood loss
was less in the warming group than in the control group
(141.13±108.82 vs. 212.73±525.31 mL) in our study, the
difference did not reach statistical significance. One possible
explanation might be that the advantages of reducing blood
loss by fluid warming may be reduced in robotic-assisted
laparoscopic surgery.
Intraoperative hypothermia has been shown to reduce the
level of circulating platelets and platelets function (21,22).
Supporting this notion, our study showed that the warming
group had a higher postoperative platelet count compared
with the control group. On the other hand, we observed that
the warming group had significantly shorter postoperative
TT than the control group. Multivariate linear regression
analysis confirmed that the warming group had shorter TT
than the control group, suggesting that fluid warming can
improve the postoperative coagulation function. Intraopera-
tive hypothermia is known to induce coagulopathy by
impairing several enzymes of the coagulation cascade,
eventually reducing clot formation (7). Both impaired
function of platelets and coagulation can lead to increase
bleeding time and intraoperative blood loss.
Yi et al. conducted a national cross-sectional study in
China on 3,132 patients under general anesthesia, and the
results demonstrate that intraoperative hypothermia would
increase intensive care unit (ICU) admissions and prolonged
hospitalization days (23). Kurz et al. have demonstrated
that maintaining normothermia intraoperatively by combin-
ing intravenous fluids warming and forced-air cover can
effectively decrease the incidence of infectious complica-
tions and hospitalization days (15). In agreement with these
observations, our study also found that compared to the
control group, the warming group had shorter hospitaliza-
tion days. This observation indicated that fluid warming can
promote postoperative recovery.
’ CONCLUSIONS
In summary, this study demonstrated that fluid warming
can effectively reduce transfusion requirement and hospita-
lization days, maintain intraoperative normothermia and pro-
mote postoperative coagulation function in elderly patients
undergoing Da Vinci robotic-assisted laparoscopic radical
cystectomy, which is worth further clinical application.
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Table 6 - Postoperative complications.
Parameters Control (n=55) Warming (n=53) Total (n=108) p
Cold shiver in recovery room 0.282
No 38 (70.37) 39 (79.59) 77 (74.76)
Yes 16 (29.63) 10 (20.41) 26 (25.24)
Pneumonia 0.963
No 52 (94.55) 50 (94.34) 102 (94.44)
Yes 3 (5.45) 3 (5.66) 6 (5.56)
Pulmonary embolism -
No 55 (100.00) 53 (100.00) 108 (100.00)
Yes 0 0 0
Urinary fistula 0.687
No 39 (70.91) 35 (67.31) 74 (69.16)
Yes 16 (29.09) 17 (32.69) 33 (30.84)
Intestinal obstruction 0.378
No 37 (67.27) 39 (75.00) 76 (71.03)
Yes 18 (32.73) 13 (25.00) 31 (28.97)
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